Global Development Medical Director, Late Respiratory and Immunology Clinical Development
AstraZeneca
Summary
As a Global Development Medical Director, you will support the clinical project team and assist the Global Clinical Project Leader and Global Clinical Head with the design & interpretation process, establishing clear design objectives for clinical programs and studies. You will provide medical input into the content of core labelling texts and medical support for commercial activities, support for medical monitoring of clinical studies. And, you will also provide medical and scientific expertise as well as tactical and strategic medical input to the development of AstraZeneca’s compounds; primarily from Phase IIb to Phase IV. This includes the design, delivery and interpretation of pivotal clinical trials and of studies that further characterize the overall benefit and risk and value of Respiratory and Immunology products in late-stage development.
Job description
What you will do:
- Be involved in providing medical and scientific leadership in the global development of new medicines targeted at indications in the field of respiratory diseases and wider range of immunological disorders
- Have an important role providing medical and scientific leadership in the innovative design, execution and interpretation of clinical trials in one or more development programs.
- Build strong relationships with a network of external scientific experts.
- Work closely with colleagues in other functions including Patient Safety, Regulatory Affairs, and Clinical Operations.
- Be involved primarily in late stage (Ph2b and later) clinical programs while also collaborating with clinical colleagues supporting Early (R&I) stage programs and medical affairs.
- Lead and contribute to medical monitoring of trials
- Provide expert medical input into the preparation of regulatory documents and interactions with regulatory authorities.
- Provide expert medical and scientific analysis and interpretation of data from ongoing studies and in the literature.
- Develop and review protocols, informed consent, investigator’s brochure and other clinical development documents.
- Participate in the preparation of scientific publications and presentations at scientific meetings and congresses.
Basic Qualifications
- MD or MD/PhD
- 3+ years of pharmaceutical industry experience, 3+ years of clinical research experience in the academic or clinical practice setting
- Demonstrated partnership and collaboration skills, including acting as the leader and clearly communicating across countries and cultures
- Fluent in oral and written English, with good presentation skills and effective communication
Desired Qualifications:
- Pulmonary medicine, Immunology, Rheumatology, Allergy, or Dermatology background is desirable.
Requirements
- MD or MD/PhD
- 3+ years of pharmaceutical industry experience, 3+ years of clinical research experience in the academic or clinical practice setting
- Demonstrated partnership and collaboration skills, including acting as the leader and clearly communicating across countries and cultures
- Fluent in oral and written English, with good presentation skills and effective communication
- Pulmonary medicine, Immunology, Rheumatology, Allergy, or Dermatology background is desirable.
Benefits
- 401(k) plan
- Paid vacation
- Paid holidays
- Paid leaves
- Medical insurance
- Prescription drug coverage
- Dental insurance
- Vision coverage
- Short-term incentive bonus
- Equity-based long-term incentive program
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.